Skip to content

Author

Lu Wang

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Tubocapsenolide A Overcomes Oxaliplatin Resistance in Colorectal Cancer by Targeting PLK1 to Impair CEP55–ESCRT‐Associated Vesicular Damage Clearance

ABSTRACT Oxaliplatin (L‐OHP) is a first‐line chemotherapeutic agent for advanced colorectal cancer (CRC) and postoperative adjuvant therapy. However, acquired L‐OHP resistance remains a clinical obstacle. Here, we identify Tubocapsenolide A (TA), a natural withanolide isolated from Tubocapsicum anomalum, as a promising...

Yue-Ying Yang, Jing-Kai Liang, Lu Wang et al. · 0 citations
Review Open access Sep 2026

Recent advances in research on the multifactorial mechanisms underlying paclitaxel resistance and translational intervention strategies

A framework for a deeper understanding of the complex biological basis of PTX resistance is provided and insights are offered into the development of more precise therapeutic strategies for overcoming resistance.

Ming-Jun Zhu, Bing-Wen Zhou, Lu Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.